Skip to main content

Table 4 Prevalence of HPyV6 and HPyV7 in non-cutaneous other human malignancies

From: Emerging role of human polyomaviruses 6 and 7 in human cancers

Tumor Specimen Samples n Method HPyV6 Positive n (%) HPyV7 Positive n (%) Reference
BC FF 54 rt-PCR 1 (2) 1 (2) [75]
LSCC FF 7 Luminex platform (Multiplex PCR) 1 (14.3) ND [76]
TETs FFPE 37 FISH/PCR/Seq/IHC ND 23 (62.2) [31]
TSCC FF 38 qPCR 2 (5.3) 1 (2.6) [57]
TC FF and FFPE 112 qPCR 6 (5.4) 2 (1.8) [58]
CCA FFPE 42 PCR/FISH/RISH/IHC 4 (9.5) 19 (45.2) [77]
  1. BC breast cancer, CCA cholangiocarcinoma, FFPE formalin-fixed paraffin-embedded, FF Freshly frozen tissue, FISH fluorescence in situ hybridization, LSCC laryngeal squamous cell carcinoma, ND not detected, PCR polymerase chain reaction, qPCR quantitative polymerase chain reaction, rt-PCR real-time polymerase chain reaction, RISH RNA fluorescence in situ hybridization, Seq Sanger sequencing, TC tonsillar carcinoma, TETs thymic epithelial tumors, TSCC tonsillar squamous cell carcinoma